PTPN2, a potential therapeutic target for type 1 diabetes?

被引：2
|
作者：
Liu, Shan-Shan [1 ]
Lou, Ji-Quan [1 ]
Ding, Ye [1 ]
机构：
[1] Shanghai Pudong Inst Hlth Dev, Dept Hlth Evaluat, Shanghai, Peoples R China
来源：
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA | 2014年 / 58卷 / 09期
关键词：
BETA-CELL APOPTOSIS; CANDIDATE GENE;
D O I：
10.1590/0004-2730000003561
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：978 / 979
页数：2
相关论文
共 50 条
  • [21] PTPN2 rs45450798 polymorphism is associated with accelerated progression of beta cell autoimmunity to clinical type 1 diabetes
    Lempainen, J.
    Laine, A. -P.
    Hammais, A.
    Veijola, R.
    Simell, O.
    Knip, M.
    Ilonen, J.
    DIABETOLOGIA, 2013, 56 : S18 - S18
  • [22] T-Cell-Specific PTPN2 Deficiency in NOD Mice Accelerates the Development of Type 1 Diabetes and Autoimmune Comorbidities
    Wiede, Florian
    Brodnicki, Thomas C.
    Goh, Pei Kee
    Leong, Yew A.
    Jones, Gareth W.
    Yu, Di
    Baxter, Alan G.
    Jones, Simon A.
    Kay, Thomas W. H.
    Tiganis, Tony
    DIABETES, 2019, 68 (06) : 1251 - 1266
  • [23] Little ones can do big things: Small molecule inhibitors target PTPN2/PTPN1 for tumor immunotherapy
    Wang, Junyu
    Qin, Shugang
    Zhang, Anren
    MEDCOMM, 2024, 5 (06):
  • [24] Ptpn2 and KLRG1 regulate the generation and in skin
    Hochheiser, Katharina
    Wiede, Florian
    Wagner, Teagan
    Freestone, David
    Enders, Matthias H.
    Olshansky, Moshe
    Russ, Brendan
    Nussing, Simone
    Bawden, Emma
    Braun, Asolina
    Bachem, Annabell
    Gressier, Elise
    McConville, Robyn
    Park, Simone L.
    Jones, Claerwen M.
    Davey, Gayle M.
    Gyorki, David E.
    Tscharke, David
    Parish, Ian A.
    Turner, Stephen
    Herold, Marco J.
    Tiganis, Tony
    Bedoui, Sammy
    Gebhardt, Thomas
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (06):
  • [25] Plin5: A potential therapeutic target for type 2 diabetes mellitus
    Wei, Mengjuan
    Wang, Yan
    Zhang, Yufei
    Qiao, Yun
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01):
  • [26] Interaction between VDR and PTPN2 Predicts Progression to Type 1 Diabetes in Children with Islet Autoimmunity. The Diabetes Autoimmunity Study in the Young (DAISY)
    Frederiksen, Brittni
    Yin, Xiang
    Liu, Edwin
    Romanos, Jihane
    Erlich, Henry
    Wijmenga, Cisca
    Rewers, Marian
    Norris, Jill M.
    DIABETES, 2011, 60 : A22 - A22
  • [27] Type 2 diabetes: ceramides as a therapeutic target?
    Hajduch, Eric
    Bourron, Olivier
    CLINICAL LIPIDOLOGY, 2013, 8 (06) : 607 - 609
  • [28] Association of Non-coding SNPs in the Autoimmune Susceptibility Gene PTPN2 with Diminished PTPN2 Expression
    Cerosaletti, Karen
    Long, S. Alice
    Ho, Jhon-Chun
    Wan, Jia Yin
    Buckner, Jane
    CLINICAL IMMUNOLOGY, 2010, 135 : S11 - S11
  • [29] PGC-1 activation: a therapeutic target for type 2 diabetes?
    Yuan, Daixiu
    Xiao, Dingfu
    Gao, Qian
    Zeng, Liming
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2019, 24 (03) : 385 - 395
  • [30] PGC-1α activation: a therapeutic target for type 2 diabetes?
    Daixiu Yuan
    Dingfu Xiao
    Qian Gao
    Liming Zeng
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2019, 24 : 385 - 395
12345